Neogen Corporation

NASDAQ

Market Cap.

1.04B

Avg. Volume

7.14M

Price

1W %

1M %

3M %

6M %

1Y %

YTD %

--

--

--

--

--

--

--

AI Generated Qualitative Analysis

AI

Your time is precious, so save it. Use AI to get the most important information from the business.

Learn about Neogen Corporation

Neogen Corporation News

Neogen Corporation Quantitative Score

Overall Score

Business

Growth

Unlock

Business

Quality

Unlock

Stock

Value

Unlock

Price

Move

Price

Momentum

Unlock

Price

Stability

Unlock
Website screenshot
HealthcareMedical - Diagnostics & Research
neogen.com

About Neogen Corporation

Neogen Corporation, together with its subsidiaries, develops, manufactures, and markets various products for food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells. This segment offers its products primarily to food and feed producers and processors; grain producers and processors; producers of cookies, crackers, candy, ice cream, and other processed foods; meat and poultry processors, seafood processors, fruit and vegetable producers, and dairies; laboratories; and producers of pharmaceuticals, cosmetics, and veterinary vaccines. The Animal Safety segment provides veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodenticides, cleaners, disinfectants, insecticides, and genomics testing services for the animal safety market. This segment offers various products for researchers to detect biologically active substances. Its drug detection immunoassay test kits are used for the detection of abused and therapeutic drugs in farm and racing animals; detection of drug residues in meat and meat products; and human forensic toxicology drug screening applications. In addition, this segment's products are used to maintain sanitary conditions and limit the potential hazards of bacteria, fungi, and viruses. Neogen Corporation was incorporated in 1981 and is headquartered in Lansing, Michigan.

Neogen Corporation Earnings & Revenue

What’s This Company Really Worth? Find Out Instantly.

Warren Buffett’s go-to valuation method is Discounted Cash Flow (DCF). Our tool makes it effortless — no spreadsheets, just answers in a few clicks.

Neogen Corporation Financials

Table Compare

Compare NEOG metrics with:

   

Earnings & Growth

NEOG

None

EPS (TTM) YoY Growth

--

--

Revenue (TTM) YoY Growth

--

--

 

Valuation (TTM)

NEOG

None

Price/Earnings Ratio

--

--

Price/Sales Ratio

--

--

 

Profitability & Efficiency (TTM)

NEOG

None

Net Profit Margin

--

--

Return on Equity

--

--

 

Financial Health (TTM)

NEOG

None

Debt/Assets Ratio

--

--

Assets/Liabilities Ratio

--

--

 

Neogen Corporation Income

Neogen Corporation Balance Sheet

Neogen Corporation Cash Flow

Neogen Corporation Financials Over Time

Analysts Rating

Strong Buy

Buy

Hold

Sell

Strong Sell

Metrics Scores

MetricsScore
Discounted Cash FlowsBuy
Return on EquityStrong Sell
Return on AssetsStrong Sell
Debt/Equity RatioSell
Price/Earnings RatioStrong Sell
Price/Book RatioBuy

Price Targets


Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.

Historical Market Cap

Shares Outstanding

Neogen Corporation Executives

NameRole
Mr. John Edward AdentPresident, Chief Executive Officer & Director
Mr. David H. NaemuraChief Operating Officer & Chief Financial Officer
Ms. Amy M. Rocklin Ph.D.Chief Legal & Compliance Officer and Corporate Secretary
Dr. Jason W. Lilly M.B.A., Ph.D.Chief Scientific Officer
Mr. Bill WaelkeHead of Investor Relations
NameRoleGenderDate of BirthPay
Mr. John Edward AdentPresident, Chief Executive Officer & DirectorMale19681.22M
Mr. David H. NaemuraChief Operating Officer & Chief Financial OfficerMale1970810.65K
Ms. Amy M. Rocklin Ph.D.Chief Legal & Compliance Officer and Corporate SecretaryFemale1972564.7K
Dr. Jason W. Lilly M.B.A., Ph.D.Chief Scientific Officer1974476.99K
Mr. Bill WaelkeHead of Investor RelationsMale

--

Neogen Corporation Insider Trades

Date2 Jun
NameWainer Andrea F
RoleDirector
TransactionAcquired
TypeA-Award
Shares6090
Date2 Jun
NameWainer Andrea F
RoleDirector
TransactionAcquired
TypeA-Award
Shares16303
Date1 Jun
NameWainer Andrea F
RoleDirector
TransactionDisposed
Type
Shares0
Date2 Jun
NameNaemura David H.
RoleChief Financial Officer
TransactionAcquired
TypeA-Award
Shares52724
Date2 Jun
NameNaemura David H.
RoleChief Financial Officer
TransactionAcquired
TypeA-Award
Shares211723
DateNameRoleTransactionTypeShares
2 JunWainer Andrea FDirectorAcquiredA-Award6090
2 JunWainer Andrea FDirectorAcquiredA-Award16303
1 JunWainer Andrea FDirectorDisposed0
2 JunNaemura David H.Chief Financial OfficerAcquiredA-Award52724
2 JunNaemura David H.Chief Financial OfficerAcquiredA-Award211723

Discover More

Streamlined Academy

Neogen Corporation

NASDAQ

Market Cap.

1.04B

Avg. Volume

7.14M

Price

1W %

1M %

3M %

6M %

1Y %

YTD %

--

--

--

--

--

--

--

Neogen Corporation News

Neogen Corporation Quantitative Score

Overall Score

Business

Growth

Unlock

Business

Quality

Unlock

Stock

Value

Unlock

Price

Move

Price

Momentum

Unlock

Price

Stability

Unlock

Neogen Corporation Earnings & Revenue

Neogen Corporation Income

Neogen Corporation Balance Sheet

Neogen Corporation Cash Flow

Neogen Corporation Financials Over Time

Neogen Corporation Executives

NameRole
Mr. John Edward AdentPresident, Chief Executive Officer & Director
Mr. David H. NaemuraChief Operating Officer & Chief Financial Officer
Ms. Amy M. Rocklin Ph.D.Chief Legal & Compliance Officer and Corporate Secretary
Dr. Jason W. Lilly M.B.A., Ph.D.Chief Scientific Officer
Mr. Bill WaelkeHead of Investor Relations
NameRoleGenderDate of BirthPay
Mr. John Edward AdentPresident, Chief Executive Officer & DirectorMale19681.22M
Mr. David H. NaemuraChief Operating Officer & Chief Financial OfficerMale1970810.65K
Ms. Amy M. Rocklin Ph.D.Chief Legal & Compliance Officer and Corporate SecretaryFemale1972564.7K
Dr. Jason W. Lilly M.B.A., Ph.D.Chief Scientific Officer1974476.99K
Mr. Bill WaelkeHead of Investor RelationsMale

--

Neogen Corporation Insider Trades

Date2 Jun
NameWainer Andrea F
RoleDirector
TransactionAcquired
TypeA-Award
Shares6090
Date2 Jun
NameWainer Andrea F
RoleDirector
TransactionAcquired
TypeA-Award
Shares16303
Date1 Jun
NameWainer Andrea F
RoleDirector
TransactionDisposed
Type
Shares0
Date2 Jun
NameNaemura David H.
RoleChief Financial Officer
TransactionAcquired
TypeA-Award
Shares52724
Date2 Jun
NameNaemura David H.
RoleChief Financial Officer
TransactionAcquired
TypeA-Award
Shares211723
DateNameRoleTransactionTypeShares
2 JunWainer Andrea FDirectorAcquiredA-Award6090
2 JunWainer Andrea FDirectorAcquiredA-Award16303
1 JunWainer Andrea FDirectorDisposed0
2 JunNaemura David H.Chief Financial OfficerAcquiredA-Award52724
2 JunNaemura David H.Chief Financial OfficerAcquiredA-Award211723

Streamlined Academy

Website screenshot
HealthcareMedical - Diagnostics & Research
neogen.com

About Neogen Corporation

Neogen Corporation, together with its subsidiaries, develops, manufactures, and markets various products for food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells. This segment offers its products primarily to food and feed producers and processors; grain producers and processors; producers of cookies, crackers, candy, ice cream, and other processed foods; meat and poultry processors, seafood processors, fruit and vegetable producers, and dairies; laboratories; and producers of pharmaceuticals, cosmetics, and veterinary vaccines. The Animal Safety segment provides veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodenticides, cleaners, disinfectants, insecticides, and genomics testing services for the animal safety market. This segment offers various products for researchers to detect biologically active substances. Its drug detection immunoassay test kits are used for the detection of abused and therapeutic drugs in farm and racing animals; detection of drug residues in meat and meat products; and human forensic toxicology drug screening applications. In addition, this segment's products are used to maintain sanitary conditions and limit the potential hazards of bacteria, fungi, and viruses. Neogen Corporation was incorporated in 1981 and is headquartered in Lansing, Michigan.

AI Generated Qualitative Analysis

AI

Your time is precious, so save it. Use AI to get the most important information from the business.

Learn about Neogen Corporation

What’s This Company Really Worth? Find Out Instantly.

Warren Buffett’s go-to valuation method is Discounted Cash Flow (DCF). Our tool makes it effortless — no spreadsheets, just answers in a few clicks.

Neogen Corporation Financials

Table Compare

Compare NEOG metrics with:

   

Earnings & Growth

NEOG

None

EPS (TTM) YoY Growth

--

--

Revenue (TTM) YoY Growth

--

--

 

Valuation (TTM)

NEOG

None

Price/Earnings Ratio

--

--

Price/Sales Ratio

--

--

 

Profitability & Efficiency (TTM)

NEOG

None

Net Profit Margin

--

--

Return on Equity

--

--

 

Financial Health (TTM)

NEOG

None

Debt/Assets Ratio

--

--

Assets/Liabilities Ratio

--

--

 

Analysts Rating

Strong Buy

Buy

Hold

Sell

Strong Sell

Metrics Scores

MetricsScore
Discounted Cash FlowsBuy
Return on EquityStrong Sell
Return on AssetsStrong Sell
Debt/Equity RatioSell
Price/Earnings RatioStrong Sell
Price/Book RatioBuy

Price Targets


Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.

Historical Market Cap

Shares Outstanding

Discover More

The Secret to Analyzing Winning Stocks (Step-by-Step Examples Inside)